What BCBS 239 means for the industry

BCBS risk data aggregation and reporting deadline is January 2016

vijay-aviur-prof
Vijay Aviur, head of risk, global markets and wholesale lending technology for India at ANZ

Whenever the topic of BCBS 239, the Basel Committee on Banking Supervision's set of guidelines regarding risk data aggregation and reporting, comes up,  people immediately tend to jump to the looming January 2016 deadline.

It's understandable why that's the focus of so many. The deadline for global systematically important banks (G-Sibs) to meet the principles put forth by BCBS is less than a year away, and a January progress report published by the Basel Committee stated 14 G-Sibs indicated

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@risk.net to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

Data analytics set to fuel change in the oil market

Privileged data insight is no longer the sole preserve of the world’s oil conglomerates. Access to insightful analytics is providing a new competitive edge for smaller and mid-sized commercial and trading firms in the oil market, helping them navigate…

Data-driven execution: looking back to see forward

Reviewing favourable outcomes and attempting to replicate them is by no means a new concept across the capital markets. Portfolio managers, execution professionals and risk managers use this principle to drive their decisions, although it is really only…

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here